Iovance Biotherapeutics Inc. appointed Timothy Morris to be CFO, effective Aug. 14.
Morris most recently served as CFO and head of business development of AcelRx Pharmaceuticals Inc.
Iovance Biotherapeutics names CFO
Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in
A Cloud Migration Plan for Corporations featuring Snowflake®
Investor Activism Campaigns Hit Record High in 2022
Essential IR Insights Newsletter - February 2023
Iovance Biotherapeutics Inc. appointed Timothy Morris to be CFO, effective Aug. 14.
Morris most recently served as CFO and head of business development of AcelRx Pharmaceuticals Inc.